近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Zou C, Xu F, Shen J, Xu S*. Identification of a Ferroptosis-Related Prognostic Gene PTGS2 Based on Risk Modeling and Immune Microenvironment of Early-Stage Cervical Cancer. J Oncol. 2022; 2022:3997562.
Liu T, Shen J, He Q, Xu S*. Identification of a Novel Immune-Related lncRNA CTD-2288O8.1 Regulating Cisplatin Resistance in Ovarian Cancer Based on Integrated Analysis. Frontiers in genetics. 2022; 13:814291.
Shen J, Liu T, Lv J, Xu S*. Identification of an Immune-Related Prognostic Gene CLEC5A Based on Immune Microenvironment and Risk Modeling of Ovarian Cancer. Frontiers in cell and developmental biology. 2021; 9:746932.
Xu F, Liu T, Zhou Z, Zou C, Xu S*. Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer. Front Immunol. 2021; 12:749369.
Shen J, Liu T, Bei Q, Xu S*. Comprehensive landscape of ovarian cancer immune microenvironment base on multi-omics integration analysis. Front Oncol. 2021; 11: 685065.
Xu F, Shen J, Xu S*. Multi-omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment. Front Genet. 2021; 12: 663617.
Xu F, Shen J, Xu S*. Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated with Remodeling in Cervical Cancer Tumor Microenvironment. Front Cell Dev Biol. 2021; 9:637400.
Dai Y, Cao Y, Kohler J, Lu A, Xu S*, Wang H*. Unbiased RNA-Seq-driven identification and validation of reference genes for quantitative RT-PCR analyses of pooled cancer exosomes. BMC Genomics. 2021; 22(1):27.
Li S#, Li Q#, Lu J, Zhao Q, Li D, Shen L, Wang Z, Liu J, Xie D, Cho William C, Xu S*, Yu Z*. Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells. Front Genet. 2020; 10: 1278-1278.
Tao Z#, Xu S#, Ruan H, Wang T, Song W, Qian L, Chen K*. MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint. Cell Physiol Biochem. 2018; 48(2):801-814.
Xu S#, Tao Z#, Hai B, Liang H, Shi Y, Wang T, Song W, Chen Y, Ou Y, Chen J, Kong F, Dong Y, Jiang S, Li W, Wang P, Yuan Z, Wan X, Wang C, Li W, Zhang X, Chen K*. miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint. Nat Commun. 2016; 5(7):11406.
Xu S#, Fu G#, Tao Z, Ou Y, Kong F, Jiang B, Wan X, Chen K*. MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1. Oncotarget. 2015; 28:26457-71.
Xu S, Wang T, Song W, Jiang T, Zhang F, Yin Y, Jiang S, Wu K, Yu Z, Wang C, Chen K*. The inhibitory effects of AR/miR- 190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism. Sci Rep. 2015; 5:13528.
Xu S, Xu P, Wu W, Ou Y, Xu J, Zhang G, Li J, Xu G*. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features. Curr Pharm Des. 2014; 20:1888–1895.
Xu S, Ren J, Chen H, Wang Y, Liu Q, Zhang R, Jiang S, Li J*. Cytostatic and Apoptotic Effects of DNMT and HDAC Inhibitors in Endometrial Cancer Cells. Curr Pharm Des. 2014; 20(11):1881-7.
Xu S, Wu W, Sun H, Lu J, Yuan B, Xia Y, Moor B, Marcha K, Wang X, Xu P, Cheng W*. Association of the Vascular Endothelial Growth Factor Gene Polymorphisms (–460C/T, +405G/C and +936T/C) with Endometriosis: A Meta-Analysis. Ann Hum Genet. 2012; 76:464-71.
He J, Wang M, Jiang Y, Chen Q, Xu S, Xu Q, Jiang B*, Liu L*. Chronic Arsenic Exposure and Angiogenesis in Human Bronchial Epithelial Cells via the ROS/miR-199a-5p/HIF-1α/COX-2 Pathway. Environ Health Perspect. 2014; 122(3):255-61.
Wang T, Liu Z, Guo S, Wu L, Li M, Yang J, Chen R, Xu H, Cai S, Chen H, Li W, Wang L, Hu Z, Zhuang Q, Xu S, Wang L, Liu J, Ye Z, Ji J, Wang C, Chen K*. The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer. Oncotarget, 2014; 5(11):3611-3621.
Wang T, Guo S, Liu Z, Wu L, Li M, Yang J, Chen R, Liu X, Xu H, Cai S, Chen H, Li W, Xu S, Wang L, Hu Z, Zhuang Q, Wang L, Wu K, Liu J, Ye Z, Ji J, Wang C, Chen K*. CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling. Oncotarget. 2014; 5(2):10293-10306.
Sun X, Jiang S, Liu J, Wang H, Zhang Y, Tang S, Wang J, Du N, Xu C, Wang C, Qin S, Zhang J, Liu D, Zhang Y, Li X, Wang J, Dong J, Wang X, Xu S, Tao Z, Xu F, Zhou J, Wang T, Ren H*. MiR-208a stimulates the cocktail of SOX2 and β-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a/let-7 feedback loop via LIN28 and DICER1. Oncotarget. 2015; 6(32):32944-54.
Xu C, Sun X, Qin S, Wang H, Zheng Z, Xu S, Luo G, Liu P, Liu J, Du N, Zhang Y, Liu D, Ren H*. Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cell. Cell cycle. 2015; 14(11):1686-97.
Chen K, Wu K*, Jiao X, Wang L, Ju X, Wang M, Di Sante, G, Xu S, Wang Q, Li KV, Sun X, Xu C, Li Z, Casimiro, MC, Ertel A, Addya S, McCue PA, Lisanti MP, Wang C, Davis RJ, Mardon G, Pestell RG*. The Endogenous Cell-Fate Factor Dachshund Restrains Prostate Epithelial Cell Migration via Repression of Cytokine Secretion via a CXCL Signaling Module. Cancer Research. 2015; 75(10):1992-2004.
Sun X, Xu C, Tang S C, Wang J, Wang H, Wang P, Du N, Qin S, Li G, Xu S, Tao Z, Liu D, Ren H*. Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells. Cancer Gene Ther. 2016; 23(4): 83-9.
Zhu L, Zhang W, Yang X, Cui L, Li J, Zhang Y, Wang Y, Ao J, Ma M, Lu H, Ren Y, Xu S, Yang G, Song W, Wang J, Zhang X, Zhang R*, Zhang Z*. Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition. Cancer Lett. 2015; 363:71-82.
京公网安备 11010802027423号